A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer
Condition(s):Gastric CancerLast Updated:November 2, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Gastric CancerLast Updated:November 2, 2016Completed
Condition(s):Colon CancerLast Updated:August 13, 2009Completed
Condition(s):BRAF V600E-mutant Metastatic Colorectal CancerLast Updated:December 21, 2023Completed
Condition(s):Pancreas Cancer; Adenocarcinoma of the PancreasLast Updated:October 3, 2023Recruiting
Condition(s):Osteosarcoma; Spindle Cell Sarcoma of BoneLast Updated:June 4, 2015Terminated
Condition(s):Metastatic Biliary Tract CancerLast Updated:August 24, 2022Completed
Condition(s):Autistic DisorderLast Updated:April 15, 2016Completed
Condition(s):HealthyLast Updated:December 31, 2013Completed
Condition(s):Stomach Cancer; Gastric CancerLast Updated:February 10, 2020Completed
Condition(s):Brain and Central Nervous System Tumors; LymphomaLast Updated:August 20, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.